IP Verse

Methods For The Treatment Of Her2 Amplified Cancer - EP3033079

EP3033079

PHARMACYCLICS
Application Number
EP14835935A
Filing Date
Aug 12, 2014
Status
Revoked
Jun 25, 2021
Grant Date
Oct 31, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3265084B1
EP2529622B1

Bibliography

The patent EP3033079B1 was granted to Pharmacyclics on Oct 31, 2018 following the initial filing on Aug 12, 2014 under the application number EP14835935A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKJul 30, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents